Title:
薬学的懸濁物
Document Type and Number:
Japanese Patent JP5661640
Kind Code:
B2
Abstract:
The present invention is directed to the provision of a pharmaceutical suspension. The suspension includes high molecular weight polyethylene glycol as a suspending agent. The suspension also typically includes an antimicrobial agent (e.g., polymeric quaternary ammonium compound), an antimicrobial system (e.g., borate/polyol complex system) or both. The suspension has been found particularly useful as an ophthalmic suspension, but can be used in other instances as well.
More Like This:
| JP2021155439 | PHARMACEUTICAL COMPOSITION |
| JP2013501033 | Controlled release formulation of lipocalin mutant protein |
| JP2005512691 | Dosage metering inhaler |
Inventors:
カブラ， バーグワティ ピー．
Application Number:
JP2011539693A
Publication Date:
January 28, 2015
Filing Date:
December 03, 2009
Export Citation:
Assignee:
アルコン リサーチ， リミテッド
International Classes:
A61K47/34; A61K9/10; A61K31/165; A61K31/382; A61K31/4709; A61K31/498; A61K31/506; A61K31/52; A61K31/5375; A61K31/542; A61K31/5575; A61K31/573; A61K45/00; A61K47/04; A61K47/10; A61K47/32; A61P27/02; A61P27/06
Attorney, Agent or Firm:
Shusaku Yamamoto
Takaaki Yasumura
Natsuki Morishita
Takaaki Yasumura
Natsuki Morishita